医学
阿司匹林
血液透析
透析
比例危险模型
动静脉瘘
内科学
混淆
胃肠道出血
外科
作者
Takeshi Hasegawa,Stacey J Elder,Jennifer L. Bragg‐Gresham,Ronald L. Pisoni,Shin Yamazaki,Tadao Akizawa,Michel Jadoul,Rayner C. Hugh,Friedrich K. Port,Shunichi Fukuhara
出处
期刊:Clinical Journal of The American Society of Nephrology
[American Society of Nephrology]
日期:2008-09-01
卷期号:3 (5): 1373-1378
被引量:45
摘要
Background and objectives: The relationship between aspirin use and arteriovenous fistula (AVF) survival has been lacking. The aim of this study was to evaluate the association between AVF survival and aspirin use. Design, setting, participants, & measurements: Data on 2815 incident hemodialysis patients (on dialysis ≤ 30 d) using an AVF at enrollment into the Dialysis Outcomes and Practice Patterns Study between 1996 and 2004 were analyzed. Cox regression was used to examine the association between aspirin use and the risk of final AVF failure, first AVF failure, and a gastrointestinal bleeding event. Aspirin use was determined at baseline and one year later. Patients using aspirin at baseline and one year later were considered consistent aspirin users. All models accounted for facility clustering effects and were adjusted for age, race, gender, body mass index, prior permanent access failure, prior placement of a catheter, 10 comorbid conditions, laboratory data, and other medications, and stratified by regions. Results: Consistent aspirin use was significantly related to a lower risk of final AVF failure. Facility-level analysis, which may reduce confounding by indication, also showed a nearly significant trend of reduced risk of final AVF failure with greater prevalence of consistent aspirin use within dialysis facilities (P for trend = 0.07). The occurrence of a new gastrointestinal bleeding event during the study period was not associated with aspirin use. Conclusions: These results suggest that consistent aspirin use may be beneficial for AVF survival among incident hemodialysis patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI